AUTH/3728/1/23 - Complainant v Bristol Myers Squibb

Alleged promotion of Zeposia (ozanimod hydrochloride)

  • Received
    11 January 2023
  • Case number
    AUTH/3728/1/23
  • Completed
    20 February 2024
  • Additional sanctions

Case Summary

As this is no breach not within the scope of the Code there is no case report